Concepedia

Rosaida Hj Md Said

RH

Statistics

Publications

3

Citations

167

H-Index

3

Active since

2023

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Western University

Janssen (United States)

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

Hospital Clínic de Barcelona

Rosaida Hj Md Said is an author at Icahn School of Medicine at Mount Sinai specializing in pharmacotherapy, clinical sciences, and inflammatory bowel disease therapy.

Publications per year

2023–2024

3

Publications

3

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

David T. Rubin, Jessica R. Allegretti, Julián Panés et al. · The Lancet · 2024 · 83 citations · Full text

, , +15

Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial

Silvio Danese, Remo Panaccione, Brian G. Feagan et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 70 citations · Full text

, , +6

Effects of one-year supplementation with Phyllanthus niruri on fibrosis score and metabolic markers in patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial

Muhammad Radzi Abu Hassan, Rosaida Hj Md Said, Zalwani Zainuddin et al. · Heliyon · 2023 · 14 citations · Full text

, , +12

1–3 of 3